受容体チロシンキナーゼは,血液形成性幹細胞および原始細胞に富んだ集団に特有である
W Matthews1, C T Jordan, G W Wiegand
1Department of Molecular Biology, Princeton University, New Jersey 08540.
Cell
|June 28, 1991
まとめ
研究者らは,新種の受容体チロシンキナーゼである胎児肝キナーゼ-2 (flk-2) を,血液形成性幹細胞で特定した. この遺伝子は,この遺伝子です.
科学分野:
- 血液学 ヘマトロジ
- 分子生物学は分子生物学である.
- 幹細胞の研究について
背景:
- 造血幹細胞 (HSC) は,血液形成に不可欠です.
- HSCの分子生物学を理解することは,再生医療の鍵です.
- HSCの機能に関与する新しい遺伝子は,識別が必要です.
研究 の 目的:
- 造血幹細胞活動を調節する遺伝子を特定する.
- 原始的造血細胞で発現する新種の遺伝子を特徴付ける.
主な方法:
- 幹細胞活動のために濃縮されたマウリン細胞集団からのcDNAの分離.
- 定量的な方法を用いた遺伝子発現分析.
- 遺伝子配列を既知の関連遺伝子と比較する.
主要な成果:
- 受容体チロシンキナーゼ,胎児肝キナーゼ-2 (flk-2) をコードする新しいcDNAが分離されました.
- flk-2発現は,幹細胞集団と原始的な祖先に限定されています.
- flk-2は,W局所遺伝子の産物であるc-kit.kitとの関連性を示しています.
結論:
- flk-2は,多能性の血液生成性幹細胞内の信号伝導に重要な役割を果たす可能性がある.
- 制限された発現パターンは,flk-2が早期の血液形成発達のマーカーであることを示唆しています.
- HSCの自己再生を理解するために,flk-2機能に関するさらなる研究が必要である.
さらに関連する動画
関連する概念動画
01:21Hematopoiesis
10.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
10.2K
01:19Multipotency of Hematopoietic Stem Cells
4.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.2K
01:21Lineage Commitment
4.6K
Commitment is the process whereby stem cells:
4.6K
01:01Regulation of Hematopoietic Stem Cells
4.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.5K
01:34Production of Formed Elements
7.0K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
7.0K
01:28Role of Hematopoietic Growth Factors
4.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.4K